Triple I Annual Meeting
The Triple I Annual meeting will be held in late March 2021. Further details will be circulated early next year.
Eureka Prize goes to leading infectious diseases researcher
Professor Gregory Dore from the Kirby Institute at UNSW Sydney has won the prestigious 2020 Eureka Prize for Infectious Disease Research.
Read more
Hepatitis C testing and treatment declines in Australia
New report shows stigma remains high despite access to highly effective treatments.
Fewer Australians are seeking testing and treatment for hepatitis C, according to a new report from Burnet and Kirby Institutes monitoring Australia’s progress in eliminating the disease.
Read more
Highly Cited Researchers 2002 list released
The Highly Cited Researchers list from Clarivate identifies scientists and social scientists who have demonstrated significant influence through publication of multiple papers, highly cited by their peers, during the last decade.
Read more
World AIDS Day: In conversation with Julie Bates AO and Professor Basil Donovan
The Kirby Institute invite you to this special online event featuring sex worker advocate Julie Bates AO, in conversation with Professor Basil Donovan, sexual health physician and Head of the Kirby Institute’s Sexual Health Program.
When: 1 December 2020
Read more
Establishing a Clinical Trials Network
The purpose of this workshop is to support Clinicians and Researchers who are interested in or have begun the process of establishing a Clinical Trial Network (CTN) and to provide an update on a range of emerging groups in the clinical trial sector.
When: 4 December 2020
Read more
Job opportunity: SPHERE Implementation Science Platform EO
The Executive Officer is an experienced nurse clinician and leader with management experience who will work directly with the Director, Maridulu Budyari Gumal Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) Implementation Science strategic platform to provide high level support for managing operational and quality research translation initiatives. Interviews are scheduled for 9 December 2020.
Deadline: COB 4 December 2020
Read more
MRFF Funding Opportunities
Triple I Vision: A world where human health is enriched by controlling infection, enhancing immunity and managing inflammation.
|